BACKGROUND: Previous studies in Alaska have demonstrated elevated proportions of antimicrobial resistance among Helicobacter pylori isolates. MATERIALS AND METHODS: We analyzed H. pylori data from the Centers for Disease Control and Prevention (CDC)'s sentinel surveillance in Alaska from July 1999 to June 2003 to determine the proportion of culture-positive biopsies from Alaska Native persons undergoing routine upper-endoscopy, and the susceptibility of H. pylori isolates to metronidazole [minimum inhibitory concentration (MIC) of > 8 g metronidazole/mL), clarithromycin (MIC > or = 1), tetracycline (MIC > or = 2) and amoxicillin (MIC > or = 1)] using agar dilution. RESULTS: Nine-hundred sixty-four biopsy specimens were obtained from 687 participants; 352 (51%) patients tested culture positive. Mean age of both culture-positive and culture-negative patients was 51 years. Metronidazole resistance was demonstrated in isolates from 155 (44%) persons, clarithromycin resistance from 108 (31%) persons, amoxicillin resistance from 8 (2%) persons, and 0 for tetracycline resistance. Metronidazole and clarithromycin resistance varied by geographic region. Female patients were more likely than male subjects to show metronidazole resistance (p < .01) and clarithromycin resistance (p = .05). CONCLUSIONS: Resistance to metronidazole and clarithromycin is more common among H. pylori isolates from Alaska Native persons when compared with those from elsewhere in the USA.
BACKGROUND: Previous studies in Alaska have demonstrated elevated proportions of antimicrobial resistance among Helicobacter pylori isolates. MATERIALS AND METHODS: We analyzed H. pylori data from the Centers for Disease Control and Prevention (CDC)'s sentinel surveillance in Alaska from July 1999 to June 2003 to determine the proportion of culture-positive biopsies from Alaska Native persons undergoing routine upper-endoscopy, and the susceptibility of H. pylori isolates to metronidazole [minimum inhibitory concentration (MIC) of > 8 g metronidazole/mL), clarithromycin (MIC > or = 1), tetracycline (MIC > or = 2) and amoxicillin (MIC > or = 1)] using agar dilution. RESULTS: Nine-hundred sixty-four biopsy specimens were obtained from 687 participants; 352 (51%) patients tested culture positive. Mean age of both culture-positive and culture-negative patients was 51 years. Metronidazole resistance was demonstrated in isolates from 155 (44%) persons, clarithromycin resistance from 108 (31%) persons, amoxicillin resistance from 8 (2%) persons, and 0 for tetracycline resistance. Metronidazole and clarithromycin resistance varied by geographic region. Female patients were more likely than male subjects to show metronidazole resistance (p < .01) and clarithromycin resistance (p = .05). CONCLUSIONS: Resistance to metronidazole and clarithromycin is more common among H. pylori isolates from Alaska Native persons when compared with those from elsewhere in the USA.
Authors: Karen Miernyk; Julie Morris; Dana Bruden; Brian McMahon; Debby Hurlburt; Frank Sacco; Alan Parkinson; Thomas Hennessy; Michael Bruce Journal: J Clin Microbiol Date: 2011-07-13 Impact factor: 5.948
Authors: Adrienne H Tveit; Michael G Bruce; Dana L Bruden; Julie Morris; Alisa Reasonover; Debby A Hurlburt; Thomas W Hennessy; Brian McMahon Journal: J Clin Microbiol Date: 2011-08-03 Impact factor: 5.948
Authors: Jason Y Park; Kerry B Dunbar; Midori Mitui; Christina A Arnold; Dora M Lam-Himlin; Mark A Valasek; Irene Thung; Chinemerem Okwara; Elizabeth Coss; Byron Cryer; Christopher D Doern Journal: Dig Dis Sci Date: 2016-02-29 Impact factor: 3.199
Authors: Dana L Bruden; Michael G Bruce; Karen M Miernyk; Julie Morris; Debby Hurlburt; Thomas W Hennessy; Helen Peters; Frank Sacco; Alan J Parkinson; Brian J McMahon Journal: World J Gastroenterol Date: 2011-11-14 Impact factor: 5.742
Authors: Ousman Secka; Douglas E Berg; Martin Antonio; Tumani Corrah; Mary Tapgun; Robert Walton; Vivat Thomas; Juan J Galano; Javier Sancho; Richard A Adegbola; Julian E Thomas Journal: Antimicrob Agents Chemother Date: 2012-12-21 Impact factor: 5.191
Authors: James William Keck; Karen M Miernyk; Lisa R Bulkow; Janet J Kelly; Brian J McMahon; Frank Sacco; Thomas W Hennessy; Michael G Bruce Journal: Can J Gastroenterol Hepatol Date: 2014-06
Authors: B J McMahon; M G Bruce; A Koch; K J Goodman; V Tsukanov; G Mulvad; M L Borresen; F Sacco; D Barrett; S Westby; A J Parkinson Journal: Epidemiol Infect Date: 2015-06-22 Impact factor: 2.451
Authors: I Thung; H Aramin; V Vavinskaya; S Gupta; J Y Park; S E Crowe; M A Valasek Journal: Aliment Pharmacol Ther Date: 2015-12-23 Impact factor: 8.171